Discovery of 2-(4-Chloro-3-(trifluoromethyl)phenyl)-N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)acetamide (CHMFL-KIT-64) as a Novel Orally Available Potent Inhibitor against Broad-Spectrum Mutants of
文献类型：期刊论文
| 作者 | Yun Wu1 ; Beilei Wang1,2; Junjie Wang1,2; Qi S(亓爽)1; Fengming Zou1,3,4; Ziping Qi1,3,4; Feiyang Liu1,3,4; Wenchao Wang1,3,4; Qingsong Liu1,2,3,4,5; Jing Liu1,3,5
|
| 刊名 | J. Med. Chem.
 |
| 出版日期 | 2019-06 |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/42689]  |
| 专题 | 医学_专题未命名 |
| 作者单位 | 1.High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui 230031, China 2.University of Science and Technology of China, Hefei, Anhui 230026, P. R. China 3.Precision Medicine Research Laboratory of Anhui Province, Hefei, Anhui 230088, P. R. China 4.Precision Targeted Therapy Discovery Center, Institute of Technology Innovation, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui 230088, P. R. China 5.Institutes of Physical Science and Information Technology, Anhui University, Hefei, Anhui 230601, P. R. China |
| 推荐引用方式 GB/T 7714 | Yun Wu,Beilei Wang,Junjie Wang,et al. Discovery of 2-(4-Chloro-3-(trifluoromethyl)phenyl)-N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)acetamide (CHMFL-KIT-64) as a Novel Orally Available Potent Inhibitor against Broad-Spectrum Mutants of[J]. J. Med. Chem.,2019. |
| APA | Yun Wu.,Beilei Wang.,Junjie Wang.,Qi S.,Fengming Zou.,...&Jing Liu.(2019).Discovery of 2-(4-Chloro-3-(trifluoromethyl)phenyl)-N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)acetamide (CHMFL-KIT-64) as a Novel Orally Available Potent Inhibitor against Broad-Spectrum Mutants of.J. Med. Chem.. |
| MLA | Yun Wu,et al."Discovery of 2-(4-Chloro-3-(trifluoromethyl)phenyl)-N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)acetamide (CHMFL-KIT-64) as a Novel Orally Available Potent Inhibitor against Broad-Spectrum Mutants of".J. Med. Chem. (2019). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。